This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakazato, M.
Right arrow Articles by Kohn, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakazato, M.
Right arrow Articles by Kohn, L. D.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, November 2000, p. 8499-8512, Vol. 20, No. 22
0270-7306/00/$04.00+0

Thyroglobulin Repression of Thyroid Transcription Factor 1 (TTF-1) Gene Expression Is Mediated by Decreased DNA Binding of Nuclear Factor I Proteins Which Control Constitutive TTF-1 Expression

Minoru Nakazato, Hyun-Kyung Chung, Luca Ulianich, Antonino Grassadonia, Koichi Suzuki, and Leonard D. Kohn*

Cell Regulation Section, Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892

Received 22 May 2000/Returned for modification 26 June 2000/Accepted 21 August 2000

Follicular thyroglobulin (TG) selectively suppresses the expression of thyroid-restricted transcription factors, thereby altering the expression of thyroid-specific proteins. In this study, we investigated the molecular mechanism by which TG suppresses the prototypic thyroid-restricted transcription factor, thyroid transcription factor 1 (TTF-1), in rat FRTL-5 thyrocytes. We show that the region between bp -264 and -153 on the TTF-1 promoter contains two nuclear factor I (NFI) elements whose function is involved in TG-mediated suppression. Thus, NFI binding to these elements is critical for constitutive expression of TTF-1; TG decreases NFI binding to the NFI elements in association with TG repression. NFI is a family of transcription factors that is ubiquitously expressed and contributes to constitutive and cell-specific gene expression. In contrast to the contribution of NFI proteins to constitutive gene expression in other systems, we demonstrate that follicular TG transcriptionally represses all NFI RNAs (NFI-A, -B, -C, and -X) in association with decreased NFI binding and that the RNA levels decrease as early as 4 h after TG treatment. Although TG treatment for 48 h results in a decrease in NFI protein-DNA complexes measured in DNA mobility shift assays, NFI proteins are still detectable by Western analysis. We show, however, that the binding of all NFI proteins is redox regulated. Thus, diamide treatment of nuclear extracts strongly reduces the binding of NFI proteins, and the addition of higher concentrations of dithiothreitol to nuclear extracts from TG-treated cells restores NFI-DNA binding to levels in extracts from untreated cells. We conclude that NFI binding to two NFI elements, at bp -264 to -153, positively regulates TTF-1 expression and controls constitutive TTF-1 levels. TG mediates the repression of TTF-1 gene expression by decreasing NFI RNA and protein levels, as well as by altering the binding activity of NFI, which is redox controlled.


* Corresponding author. Mailing address: Cell Regulation Section, Metabolic Diseases Branch, NIDDK, Bldg. 10, Room 9C101B, NIH, Bethesda, MD 20892-1800. Phone: (301) 496-3564. Fax: (301) 496-0200. E-mail: Lenk{at}bdg10.niddk.nih.gov.


Molecular and Cellular Biology, November 2000, p. 8499-8512, Vol. 20, No. 22
0270-7306/00/$04.00+0



This article has been cited by other articles:

  • Yaden, B. C., Garcia, M. III, Smith, T. P. L., Rhodes, S. J. (2006). Two Promoters Mediate Transcription from the Human LHX3 Gene: Involvement of Nuclear Factor I and Specificity Protein 1. Endocrinology 147: 324-337 [Abstract] [Full Text]  
  • Charmandari, E., Kino, T., Souvatzoglou, E., Vottero, A., Bhattacharyya, N., Chrousos, G. P. (2004). Natural Glucocorticoid Receptor Mutants Causing Generalized Glucocorticoid Resistance: Molecular Genotype, Genetic Transmission, and Clinical Phenotype. J. Clin. Endocrinol. Metab. 89: 1939-1949 [Abstract] [Full Text]  
  • Bachurski, C. J., Yang, G. H., Currier, T. A., Gronostajski, R. M., Hong, D. (2003). Nuclear Factor I/Thyroid Transcription Factor 1 Interactions Modulate Surfactant Protein C Transcription. Mol. Cell. Biol. 23: 9014-9024 [Abstract] [Full Text]  
  • Vottero, A., Kino, T., Combe, H., Lecomte, P., Chrousos, G. P. (2002). A Novel, C-Terminal Dominant Negative Mutation of the GR Causes Familial Glucocorticoid Resistance through Abnormal Interactions with p160 Steroid Receptor Coactivators. J. Clin. Endocrinol. Metab. 87: 2658-2667 [Abstract] [Full Text]  
  • Puzianowska-Kuznicka, M., Krystyniak, A., Madej, A., Cheng, S.-Y., Nauman, J. (2002). Functionally Impaired TR Mutants Are Present in Thyroid Papillary Cancer. J. Clin. Endocrinol. Metab. 87: 1120-1128 [Abstract] [Full Text]